{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T08:23:11Z","timestamp":1759134191134,"version":"3.44.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.radonc.2020.05.016","type":"journal-article","created":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T16:04:29Z","timestamp":1589472269000},"page":"168-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Acute organ toxicity correlates with better clinical outcome after chemoradiotherapy in patients with anal carcinoma"],"prefix":"10.1016","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8674-2683","authenticated-orcid":false,"given":"Daniel","family":"Martin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"R\u00f6del","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"von der Gr\u00fcn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"R\u00f6del","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanouil","family":"Fokas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2020.05.016_b0005","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/CEJ.0000000000000163","article-title":"Trends of incidence and survival in squamous-cell carcinoma of the anal canal in France: a population-based study","volume":"25","author":"Bouvier","year":"2016","journal-title":"Eur J Cancer Prev Off J Eur Cancer Prev Organ ECP"},{"key":"10.1016\/j.radonc.2020.05.016_b0010","article-title":"Rising Incidence and Improved Survival of Anal Squamous Cell Carcinoma in Norway, 1987\u20132016","author":"Guren","year":"2018","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.radonc.2020.05.016_b0015","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 \u00d7 2 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2020.05.016_b0020","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","article-title":"Long-term update of US GI intergroup RTOG 98\u201311 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin","volume":"30","author":"Gunderson","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2020.05.016_b0025","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.ijrobp.2018.04.009","article-title":"Acute Epithelial Toxicity Is Prognostic for Improved Prostate Cancer Response to Radiation Therapy: A Retrospective, Multicenter","volume":"101","author":"Eade","year":"2018","journal-title":"Cohort Study. Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2020.05.016_b0030","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00066-014-0801-3","article-title":"High-grade acute organ toxicity and p16(INK4A) expression as positive prognostic factors in primary radio(chemo)therapy for patients with head and neck squamous cell carcinoma","volume":"191","author":"Tehrany","year":"2015","journal-title":"Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al"},{"key":"10.1016\/j.radonc.2020.05.016_b0035","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1748-717X-9-217","article-title":"Association between radiation pneumonitis and tumor response in patients with NSCLC treated with chemoradiation","volume":"9","author":"MacManus","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2020.05.016_b0040","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/dote.12067","article-title":"Increasing toxicity during neoadjuvant radiochemotherapy as positive prognostic factor for patients with esophageal carcinoma","volume":"27","author":"Hennies","year":"2014","journal-title":"Dis Esophagus Off J Int Soc Dis Esophagus"},{"key":"10.1016\/j.radonc.2020.05.016_b0045","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ijrobp.2011.07.019","article-title":"Inverse relationship between biochemical outcome and acute toxicity after image-guided radiotherapy for prostate cancer","volume":"83","author":"Vesprini","year":"2012","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2020.05.016_b0050","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ijrobp.2010.01.010","article-title":"High-grade acute organ toxicity as a positive prognostic factor in primary radiochemotherapy for anal carcinoma","volume":"79","author":"Wolff","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.05.016_b0055","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1148\/radiol.10100705","article-title":"High-grade acute organ toxicity as positive prognostic factor in adjuvant radiation and chemotherapy for locally advanced head and neck cancer","volume":"258","author":"Wolff","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2020.05.016_b0060","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00066-009-2037-1","article-title":"High-grade acute organ toxicity during preoperative radiochemotherapy as positive predictor for complete histopathologic tumor regression in multimodal treatment of locally advanced rectal cancer","volume":"186","author":"Wolff","year":"2010","journal-title":"Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al"},{"key":"10.1016\/j.radonc.2020.05.016_b0065","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s00066-010-2136-z","article-title":"High-grade acute organ toxicity as positive prognostic factor in primary radio(chemo)therapy for locally advanced, inoperable head and neck cancer","volume":"186","author":"Wolff","year":"2010","journal-title":"Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al"},{"key":"10.1016\/j.radonc.2020.05.016_b0070","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ijrobp.2004.03.036","article-title":"Early FDG-PET imaging after radical radiotherapy for non-small-cell lung cancer: inflammatory changes in normal tissues correlate with tumor response and do not confound therapeutic response evaluation","volume":"60","author":"Hicks","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.05.016_b0075","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF03038718","article-title":"Acute radiation reaction and local control in breast cancer patients treated with postmastectomy radiotherapy","volume":"174","author":"Kuhnt","year":"1998","journal-title":"Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al"},{"key":"10.1016\/j.radonc.2020.05.016_b0080","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/02841869409098437","article-title":"Do acute side-effects during radiotherapy predict tumour response in rectal carcinoma?","volume":"33","author":"Dahl","year":"1994","journal-title":"Acta Oncol Stockh Swed"},{"key":"10.1016\/j.radonc.2020.05.016_b0085","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/1748-717X-9-172","article-title":"Risk and predictors for early radiation pneumonitis in patients with stage III non-small cell lung cancer treated with concurrent or sequential chemoradiotherapy","volume":"9","author":"Dang","year":"2014","journal-title":"Radiat Oncol Lond Engl"},{"year":"2008","series-title":"A language and environment for statistical computing","author":"Development Core","key":"10.1016\/j.radonc.2020.05.016_b0090"},{"key":"10.1016\/j.radonc.2020.05.016_b0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","article-title":"RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal","volume":"86","author":"Kachnic","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.05.016_b0100","article-title":"Association of sex with toxic effects, treatment adherence, and oncologic outcomes in the CAO\/ARO\/AIO-94 and CAO\/ARO\/AIO-04 phase 3 randomized clinical trials of rectal cancer","author":"Diefenhardt","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2020.05.016_b0105","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/ejh.12400","article-title":"Severe radiotoxicity in an allogeneic transplant recipient with a heterozygous ATM mutation","volume":"95","author":"Ostendorf","year":"2015","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.radonc.2020.05.016_b0110","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1200\/JCO.2011.40.1430","article-title":"Radiation therapy and adjuvant chemotherapy in a patient with a malignant glioneuronal tumor and underlying ataxia telangiectasia: a case report and review of the literature","volume":"31","author":"DeWire","year":"2013","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.radonc.2020.05.016_b0115","doi-asserted-by":"crossref","first-page":"10312","DOI":"10.18632\/oncotarget.14400","article-title":"Genomic analysis of exceptional responders to radiotherapy reveals somatic mutations in ATM","volume":"8","author":"Ma","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.radonc.2020.05.016_b0120","doi-asserted-by":"crossref","first-page":"e498","DOI":"10.1016\/S1470-2045(15)00007-8","article-title":"Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy","volume":"16","author":"Sharabi","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2020.05.016_b0125","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1158\/1078-0432.CCR-14-3110","article-title":"From DNA damage to nucleic acid sensing: a strategy to enhance radiation therapy","volume":"22","author":"Deng","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2020.05.016_b0130","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni.3558","article-title":"Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing","volume":"17","author":"Chen","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.radonc.2020.05.016_b0135","doi-asserted-by":"crossref","DOI":"10.1038\/nrclinonc.2016.211","article-title":"Radiotherapy and immunotherapy: a beneficial liaison?","author":"Weichselbaum","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.radonc.2020.05.016_b0140","first-page":"7","article-title":"Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis","author":"Xing","year":"2019","journal-title":"J ImmunoTher Cancer"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814020302693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814020302693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:11:32Z","timestamp":1759122692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814020302693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":28,"alternative-id":["S0167814020302693"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2020.05.016","relation":{},"ISSN":["0167-8140"],"issn-type":[{"type":"print","value":"0167-8140"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute organ toxicity correlates with better clinical outcome after chemoradiotherapy in patients with anal carcinoma","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2020.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}